Crizotinib (Oral Route)

3 imperatives to transform health care in America. You're invited to watch it live

Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Crizotinib (Oral Route)

Drug Information provided by: Micromedex

US Brand Names

  • Xalkori

Description

Crizotinib is used to treat advanced or metastatic (lung cancer that has already spread) non-small cell lung cancer or NSCLC that is caused by a defect in gene called anaplastic lymphoma kinase (ALK).

This medicine is available only with your doctor's prescription.

This product is available in the following dosage forms:

  • Capsule
Before Using
DR603499 Portions of this document last updated: Dec. 1, 2012

Source: Drug Information provided by: Micromedex

Copyright © 2013 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.

Advertisement


Text Size: smaller largerlarger